Objective To perform a comparative analysis of postthyroidectomy radioactive iodine
ablation dosing with or without the implementation of a diagnostic whole-body scan in …

Objectives The aim of this study was to compare ablation success and disease-free survival
(DFS) on the basis of different ablation doses. Methods This retrospective study enrolled …

Background: The utility of radioiodine (RAI) scans prior to 131I ablation is controversial. The
objective of this study was to evaluate the utility of RAI scans prior to 131I ablation in patient …

Background: Radioiodine (131I) remnant ablation (RRA) has become a key step in the
postoperative treatment of differentiated thyroid cancer (DTC). However, inadequate or …

Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration …

Objective The mute question is whether patients with DTC of intermediate risk of recurrence,
second most common presentation, who were surgically ablated in the first place, ever …

Purpose The present study was undertaken to evaluate the ablation rate after administration
of 1.1 or 3.7 GBq of iodine-131 (131 I) to patients with low-risk differentiated thyroid …

Aim The aim of this study was to assess ablation outcome after a second ablation dose and
compare the ablation rate after low and high reablation doses of iodine-131 (131 I) after …

Objective Differentiated thyroid cancer is rare, but the incidence has been increasing in the
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …

Abstract Objective The 2015 American Thyroid Association guidelines recommend against
radioiodine (RAI) ablation for patients with low‐risk papillary microcarcinoma. However, its …